Overview of RESONATE-2 clinical trial of ibrutinib in CLL
John Gribben et al.
From one generation to the next: the progression of CLL research
What are the economics of treating CLL?
Treatment-associated atrial fibrillation: ibrutinib-specific or class-specific?
The use of venetoclax (ABT-199) in the treatment of CLL